TABLE 4.
Treatment and posttreatment sequence changesa
| Region and treatment | SVR (n = 3) | NR (n = 15) |
|---|---|---|
| PKRBD region | ||
| Baseline | 4.67 ± 0.57 | 3.8 ± 0.86 |
| First-mo treatment | 4.67 ± 0.57 | 4 ± 1 |
| Posttreatment | 4.38 ± 1.68 | |
| V3 and flanking region | ||
| Baseline | 11.33 ± 2.3 | 11.67 ± 1.67b |
| First-mo treatment | 11.67 ± 2.0 | 10.83 ± 2.25c |
| Posttreatment | 13.29 ± 0.56 |
a
Data are expressed as means ± standard deviations. Comparisons between groups were made by the Student t test for the quantitative variables. A P value of <0.05 was considered statistically significant.
b
Posttreatment versus basal value differences were statistically significant (P = 0.06).
c
Posttreatment versus first-month treatment value differences were statistically significant (P = 0.05).